Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis

ClinicalTrials.gov ID: NCT01484119

Public ClinicalTrials.gov record NCT01484119. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 5:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-center, Double-blind, Double-dummy, Randomized, Placebo-controlled, Active-reference, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-129968 in Adolescent, Adult & Elderly Patients With Seasonal Allergic Rhinitis

Study identification

NCT ID
NCT01484119
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Idorsia Pharmaceuticals Ltd.
Industry
Enrollment
630 participants

Conditions and interventions

Interventions

  • ACT-129968 Drug
  • Placebo Drug
  • Cetirizine Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 76 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2011
Primary completion
Jan 31, 2012
Completion
Feb 29, 2012
Last update posted
Sep 27, 2018

2011 – 2012

United States locations

U.S. sites
7
U.S. states
1
U.S. cities
4
Facility City State ZIP Site status
Clinical Investigative Site 7905 Austin Texas 78731
Clinical Investigative Site 7907 Kerrville Texas 78028
Clinical Investigative Site 7903 New Braunfels Texas 78130
Clinical Investigative Site 7901 San Antonio Texas 78229
Clinical Investigative Site 7902 San Antonio Texas 78229
Clinical Investigative Site 7904 San Antonio Texas 78229
Clinical Investigative Site 7906 San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01484119, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 27, 2018 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01484119 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →